Thrombocytopenia clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, not currently recruiting here
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding.
San Francisco, California and other locations